Skip to main content
Equibles
URGN logo

URGN · UroGen Pharma Ltd.

Track URGN — free

Use URGN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$43.62 -1.88 (-4.13%) At close · Aug 28
Russell 2000 member Rebalance outlook locked
Going-concern doubt — cleared Aug 5, 2026

The latest filing states the doubt was alleviated.

“Based on our cash and cash equivalents and marketable securities as of June 30, 2026, together with management's cash flow projections, we believe we have sufficient cash and cash equivalents to fund our operations beyond one year from the issuance of our condensed consolidated financial statements appearing elsewhere in this Quarterly Report.”
View the 10-Q filed Aug 5, 2026
Market Cap
$2.13B
Shares
48.88M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

URGN Short Interest Forecast

Equibles' model estimates 5,279,736 shares sold short for the August 31, 2026 settlement, +3.1% versus the latest reported position. This model prediction uses FINRA data through August 21, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 21
5,279,736 +3.1% vs reported
The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
76/100
Short interest 10.5% of shares — P91 Days to cover 4.8 — P67 Price vs VWAP +9.3% — P80 Short-volume trend +10.3% — P82 Short interest change +11.6% — P78 Worst FTD 0.00% of shares — P34

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 5,120,407 4,589,109 +531,298 4.80
    2026-07-31 4,589,109 5,689,384 -1,100,275 6.64
    2026-07-15 5,689,384 6,218,229 -528,845 6.90
    2026-06-30 6,218,229 6,557,146 -338,917 9.42
    2026-06-15 6,557,146 6,921,016 -363,870 9.87
    2026-05-29 6,921,016 6,764,905 +156,111 11.09
    2026-05-15 6,764,905 7,236,438 -471,533 5.82
    2026-04-30 7,236,438 7,826,923 -590,485 8.88
    2026-04-15 7,826,923 8,348,466 -521,543 11.19
    2026-03-31 8,348,466 8,629,222 -280,756 11.83
    2026-03-13 8,629,222 8,018,559 +610,663 7.84
    2026-02-27 8,018,559 9,335,645 -1,317,086 10.84
    2026-02-13 9,335,645 10,298,661 -963,016 15.12
    2026-01-30 10,298,661 10,568,458 -269,797 14.56
    2026-01-15 10,568,458 9,541,727 +1,026,731 14.52
    2025-12-31 9,541,727 7,739,834 +1,801,893 13.54
    2025-12-15 7,739,834 7,950,298 -210,464 8.25
    2025-11-28 7,950,298 8,976,703 -1,026,405 7.29
    2025-11-14 8,976,703 11,283,704 -2,307,001 5.34
    2025-10-31 11,283,704 11,148,494 +135,210 13.57
    2025-10-15 11,148,494 8,715,101 +2,433,393 9.95
    2025-09-30 8,715,101 7,943,465 +771,636 7.32
    2025-09-15 7,943,465 7,017,727 +925,738 5.89

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1668243 CUSIP M96088105 13F (30d) 167 filings 167 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)